Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Roundup: Zantac 150 Choices, Nature's Health Warning

This article was originally published in The Tan Sheet

Executive Summary

More Zantac 150 choices; Nature's Health warned on claims, GMPs; Marine Ingredients adds Swiss Caps plant; and more news in brief.

You may also be interested in...



Health, Beauty And Wellness Transaction News: SlimFast To Glanbia, More MedMen Moves, Empower Production Partner

Glanbia adds SlimFast to its lineup; MedMen making moves in cannabis market; and production partner for Empower medical cannabis.

Sanofi Looks To Climb Consumer Ladder In Boehringer Business Swap

A pending agreement includes a $5.2bn cash payment from Boehringer to Sanofi but excludes Boehringer’s consumer product business in China. The brands Sanofi will add to its consumer health lineup include two marketed in the US, Dulcolax constipation relief and Zantac heartburn remedy.

Keeping Track: US FDA Clears Esperion’s Nexletol, Baudax’ Anjeso, Agile’s Twirla

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Topics

Related Companies

UsernamePublicRestriction

Register

PS108085

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel